Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection

Keisuke Hino1, Sohij Nishina1, Kyo Sasaki1

  • 1Department of Hepatology and Pancreatology, Kawasaki Medical School, 577 Matsushima Kurashiki, Okayama 701-0192, Japan.

Insights

Hepatitis C virus (HCV) infection causes liver injury and hepatocellular carcinoma (HCC) through oxidative stress, mitochondrial damage, and iron accumulation. Understanding these mechanisms is key to preventing HCC in chronic hepatitis C patients.

Area of Science:

  • Hepatology
  • Viral Hepatitis
  • Oncogenesis

Background:

  • Hepatitis C virus (HCV) infection frequently leads to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC).
  • Despite advances in antiviral treatments, HCV remains a significant cause of HCC.
  • Oxidative stress, mitochondrial damage, and iron accumulation are implicated in HCV-related liver injury and HCC development.

Purpose of the Study:

  • To review and discuss the mechanisms by which HCV induces mitochondrial damage and iron accumulation in the liver.
  • To offer new insights into the link between mitochondrial damage, iron accumulation, and HCC development in chronic hepatitis C.

Main Methods:

  • Literature review and discussion of existing research on HCV, oxidative stress, mitochondrial function, and iron metabolism.
  • Analysis of the role of mitochondria as a source of reactive oxygen species and iron's contribution to oxidative damage via the Fenton reaction.

Main Results:

  • HCV infection is associated with increased oxidative stress compared to other liver diseases.
  • Hepatocellular mitochondria alterations and iron accumulation are characteristic of chronic hepatitis C.
  • Phlebotomy, an iron reduction method, is used to lower transaminase levels in chronic hepatitis C patients.

Conclusions:

  • Mitochondrial damage and iron accumulation are critical factors in HCV-induced hepatocarcinogenesis.
  • Further research into these mechanisms may reveal novel therapeutic targets for preventing HCC in HCV patients.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
233
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K
What is Metabolism?00:52

What is Metabolism?

Overview
131.9K
What are Viruses?00:50

What are Viruses?

Overview
128.2K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.2K
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K